According to new research, scientists have a new vaccine that that more than 70 percent effective against rotavirus that used to give diarrhea to children and was the reason behind the deaths of more than 200,000 deaths in many developing countries. Even though there are a number of vaccines available, this is specially designed for the developing countries where the children need it the most. This vaccine can easily be stored at room temperature and will not be spoiled even at a temperature of 100 degrees, making it perfect for use in developing countries like Africa, Asia, and Bhutan. There have been a number of researches done on these vaccines, and one of the companies in the forefront of such studies is the Seattle Genetics Company. The company has risen to new heights due to its dedication to finding a cure for many diseases and also vaccines for diseases that has been troubling humanity for many decades.
The reason behind the success of Seattle Genetics Company is its CEO Clay Siegall, who is also the Chairman and the President of the company. Dr. Siegall started the company back in 1998 and carried out many different types of research. The company was among the fastest growing companies in the US according to Forbes. Over a span of five years, the company managed to triple its stock because of its flagship drug called the ADCETRIS. Currently, the company is working on introducing antibody that will help treat cancer. The company has many licenses to its name, especially for its technology such as AbbVie, GlaxoSmithKline, Roche and more.
Dr, Siegall, being a scientist himself, overlooks the management of the company. He is hardworking and encourages employees to work towards their goal with passion. He has over 70 successful publications to his name and has been the recipient of many awards. Dr. Siegall also has more than 70 patents to his name. With Siegall taking the company to new heights with his dedication, the company is set to become a major player in the industry not just in the US, but in the world as well.